ID   UK Pan-1
AC   CVCL_UW41
DR   cancercelllines; CVCL_UW41
DR   IARC_TP53; 17901
DR   Wikidata; Q98133936
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=10813711;
CC   Doubling time: <24 hours (PubMed=10813711).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=10813711).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (PubMed=10813711).
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
RX   DOI=10.4172/2324-9293.1000104;
RA   Wagenhauser M.U., Ruckert F., Niedergethmann M., Grutzmann R.,
RA   Saeger H.-D.;
RT   "Distribution of characteristic mutations in native ductal
RT   adenocarcinoma of the pancreas and pancreatic cancer cell lines.";
RL   Cell Biol. Res. Ther. 2:1000104.1-1000104.5(2013).
//
RX   PubMed=10813711; DOI=10.1002/(SICI)1097-0142(20000501)88:9<2010::AID-CNCR5>3.0.CO;2-5;
RA   Fralix K.D., Ahmed M.M., Mattingly C., Swiderski C., McGrath P.C.,
RA   Venkatasubbarao K., Kamada N., Mohiuddin M., Strodel W.E.,
RA   Freeman J.W.;
RT   "Characterization of a newly established human pancreatic carcinoma
RT   cell line, UK Pan-1.";
RL   Cancer 88:2010-2021(2000).
//